Chlorantraniliprole Patent Landscape Analysis

Originating from E.I. du Pont de Nemours and now forming the foundation of FMC’s Rynaxypyr® insect-control portfolio, chlorantraniliprole is one of the world’s most commercially important diamide insecticides. Its rapid feeding cessation, extended residual activity and broad crop applicability have made it an industry-leading technology, registered in more than 120 countries. FMC Rynaxypyr technology

The scale of follow-on patent activity reflects that commercial importance. The updated landscape retains 931 patent families across 477 consolidated owner groups, with 690 families carrying a granted-active or national-pending reading. China-based applicants account for 720 retained families.

Combination development dominates the estate: 508 families are distributed among 305 holder groups, with 40 partner active ingredients specifically detected in claims and a further 326 families claiming combinations in broader terms. The upstream landscape contains 28 compound, eight crystal-form and 169 process and intermediate families, while 132 families protect single-active formulations. Eighty-six live families reach their nominal term within five years.

This 203-page report provides complete analysis of ownership, manufacture, formulations, combinations, national market entry and major owner portfolios, followed by a directory covering all 477 owner groups and detailed patent tables for every retained family.

Not a freedom-to-operate opinion.